Trial Profile
Feasibility study of maintenance therapy of TS-1 for stage IV non-small cell lung cancer
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2013
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 22 Sep 2013 New trial record